Washington, D.C., October 31, 2004 – Investigators from Virco today presented data that establishes a comprehensive set of clinical cutoffs -- a newly established threshold for optimal selection and ...
NEW YORK (CBS.MW) -- Orasure Technologies climbed 6 percent in early trade after the Food and Drugs Administration approved its OraQuick Rapid HIV-1 Antibody Test for use in detecting HIV-1 antibodies ...
COBAS TaqMan HIV-1 Test, v2.0 uses a dual-target approach to increase reliability. Roche’s COBAS® TaqMan® HIV-1 Test, v2.0, has been approved by the FDA. The test will be commercially available in the ...
This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory. Objectives: To understand real-world implementation of the updated CDC HIV ...
– Positive Opinion Also Received for EMA’s EU-M4all Procedure, Designed to Facilitate Availability in Low- and Lower-Middle-Income Countries – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that ...
The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent HIV, the creator of the drug, Gilead Sciences, announced on Wednesday. Sold ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback